Northern Financial Advisors’s AbbVie ABBV Stock Holding History

Northern Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$821K	Buy	3,775 +1,352	+56%	+$300K	0.6%	54
2025 Q4	$554K	Sell	2,423 -1,500	-38%	-$342K	0.63%	48
2025 Q3	$908K	Sell	3,923 -46	-1%	-$9.37K	0.48%	57
2025 Q2	$737K	Buy	3,969 +563	+17%	+$105K	0.55%	52
2025 Q1	$714K	Sell	3,406 -51	-1%	-$9.91K	0.59%	55
2024 Q4	$614K	Sell	3,457 -101	-3%	-$18.6K	0.49%	59
2024 Q3	$703K	Sell	3,558 -17	-0.5%	-$3.17K	0.53%	60
2024 Q2	$613K	Hold	3,575	–	–	0.49%	64
2024 Q1	$651K	Sell	3,575 -20	-0.6%	-$3.45K	0.51%	67
2023 Q4	$557K	Sell	3,595 -944	-21%	-$138K	0.47%	67
2023 Q3	$677K	Buy	4,539 +662	+17%	+$97.2K	0.62%	51
2023 Q2	$522K	Sell	3,877 -787	-17%	-$115K	0.46%	67
2023 Q1	$743K	Buy	+4,664	New	+$713K	0.7%	47

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Financial Advisors's ABBV Position: Q1 2026 in Review

Northern Financial Advisors increased its AbbVie (ABBV) stake by 56% in Q1 2026, buying an estimated $300K and bringing the position to 3,775 shares worth $821K. The position accounts for 0.6% of the portfolio, ranked #54.

Northern Financial Advisors first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $908K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Northern Financial Advisors held 3,775 shares of AbbVie worth $821K as of Q1 2026.
Northern Financial Advisors bought 1,352 AbbVie shares in Q1 2026, an estimated $300K.
AbbVie made up 0.6% of Northern Financial Advisors's portfolio in Q1 2026, its #54 holding.
Northern Financial Advisors first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Northern Financial Advisors's AbbVie position peaked at $908K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Northern Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.